X
Xin Li
Publications - 9
Citations - 456
Xin Li is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 409 citations.
Papers
More filters
IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS FOR VIDEO TECHNOLOGY Editor-in-Chief
Chang Wen Chen,Hamid Gharavi,Thomas Sikora,Ishfaq Ahmad,John F. Arnold,Oscar Au,Mauro Barni,Vincent Bottreau,Jill Macdonald Boyce,Thomson Corp,Jianfei Cai,Homer H. Chen,Shao-Yi Chien,Mary Comer,Paulo Lobato Correia,Ricardo De Queiroz,Pascal Frossard,Toshiaki Fujii,Wen Gao,Richard Green,Yo-Sung Ho,Ebroul Izquierdo,Queen Mary,Rosa C. Lancini,Shipeng Li,Xin Li,Xuelong Li,Antonio Navarro,Sharath Pankanti,Justin Ridge,Yong Rui,Dan Schonfeld,Eckehard Steinbach,Sanghoon Sull,Huifang Sun,Clark N. Taylor,Deepak Turaga,Gene Wen,Thomas Wiegand,Dapeng Oliver Wu,Jar-Ferr Yang,Haoping Yu +41 more
TL;DR: This special issue, which focuses on event analysis in broad problem domains, has witnessed the effectiveness of using both static and temporal information in event recognition from other video sources.
Journal ArticleDOI
CD19 or CD20 CAR T-cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with CNS Lymphoma.
Ruiqiang Li,Qian-Qian Cheng,Liqing Kang,Erhua Wang,Ying Li,Jian Zhang,Hang Xiao,Yi Kan Zhang,Ling Chu,Xin Chen,Chang-Qing Zhang,Jingwen Tan,Nan Xu,Minghao Li,Lei Yu,Xin Li +15 more
TL;DR: The results of this study suggest that CD19 or CD20 CAR T-cells are effective against central nervous system (CNS) lymphoma.
Journal ArticleDOI
Deputy Editor-in-Chief
Chang Wen Chen,Hamid Gharavi,Thomas Sikora,Ishfaq Ahmad,John F. Arnold,Oscar Au,Jill Macdonald Boyce,Thomson Corp,Homer Chen,Liang-Gee Chen,Paulo Lobato Correia,Ricardo De Queiroz,Pascal Frossard,Toshiaki Fujii,Wen Gao,Ling Guan,Yo-Sung Ho,Ebroul Izquierdo,Queen Mary,Alex C. Kot,Rosa C. Lancini,Shipeng Li,Xin Li,Levent Onural,Yong Rui,Eckehard Steinbach,Huifang Sun,Qibin Sun,Kou-Hu Tzou,Mihaela van der Schaar,Susie Wee,Thomas Wiegand,Dapeng Oliver Wu,Jian Zhang +33 more
TL;DR: In this paper, the authors present a bidder list for the Journal of Experimental Biology (JEB) which includes the following authors: Stephen C. Jeb et al. (The Company of Biologists Limited Bidder Building Station Road Histon Cambridge CB24 9LF, UK Tel: +44 1223 632871 Fax:+44 12 23 632873 jeb@biologists.com Editorial Advisory Board
Journal ArticleDOI
The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections
Linli Lu,Cong Xu,Yishu Tang,Liwen Wang,Qian-Qian Cheng,Xin Chen,Jian Zhang,Ying Li,Hang Xiao,Xin Li +9 more
Abstract: Background Carbapenem-resistant Gram-negative bacteria (CRGNB) bloodstream infection (BSI) pose a significant threat to the prognosis of hematologic malignancies (HM) patients. Understanding the distribution of pathogenic bacteria, changes in carbapenem-resistant trends, risk factors for CRGNB infections, and exploring the early detection measures can help reduce mortality. Methods We conducted a multicenter retrospective study of Gram-negative bacteria (GNB) BSI in patients with HM in three university-affiliated hospitals in Hunan Province, China, from January 2010 to December 2020. Demographic and clinical data were collected from the hospital electronic medical records system. Results CRGNB caused 138 (15.3%) of 902 GNB BSI. The detection rate of CRGNB increased from 6.4% in 2010–2012 to 35.4% in 2019–2020. The 7-day mortality rate was significantly higher in patients with CRGNB BSI than in patients with carbapenem-susceptible Gram-negative bacteria (CSGNB) BSI [31.9% (44/138) vs 9.7% (74/764), P < 0.001], and the mortality rate in patients with carbapenem-resistant non-fermenting bacteria (CRNFB) bloodstream infections was generally higher than that of carbapenem-resistant Enterobacteriaceae (CRE). Urinary catheter (OR, 2.814; CI=1.395–5.680; P=0.004) and prior exposure to carbapenem (OR, 4.372; CI=2.881–6.635; P<0.001) were independent risk factors for CRGNB BSI. Analysis of co-infections showed that 50%–85% of patients with CRGNB BSI had pulmonary infections, sputum culture results suggested that sputum culture positivity rate was as high as 57.1%–66.7% in patients with carbapenem-resistant Acinetobacter baumannii (CRAB) and Stenotrophomonas maltophilia BSI, and the results of antimicrobial susceptibility testing of sputum cultures were consistent with the blood cultures. Conclusion Carbapenem resistance has dramatically increased in HM patients with GNB BSI in recent years and is associated with a worse outcome, especially for non-fermenting bacteria. In high-risk patients, early screening of the respiratory tract specimens may help to detect CRNFB colonization and protect patients from breakthrough BSI.
Journal ArticleDOI
Multiple-Inputs Convolutional Neural Network for COVID-19 Classification and Critical Region Screening From Chest X-ray Radiographs: Model Development and Performance Evaluation
TL;DR: Overall, MI-CNNs could achieve higher accuracy with an increasing number of inputs (eg, 16-input MI- CNN).